UY31880A - Composiciones farmacéuticas mejoradas que contienen un medicamento antibiótico de fluoroquinolona - Google Patents

Composiciones farmacéuticas mejoradas que contienen un medicamento antibiótico de fluoroquinolona

Info

Publication number
UY31880A
UY31880A UY0001031880A UY31880A UY31880A UY 31880 A UY31880 A UY 31880A UY 0001031880 A UY0001031880 A UY 0001031880A UY 31880 A UY31880 A UY 31880A UY 31880 A UY31880 A UY 31880A
Authority
UY
Uruguay
Prior art keywords
pharmaceutical compositions
compositions containing
medicinal product
improved pharmaceutical
compositions
Prior art date
Application number
UY0001031880A
Other languages
English (en)
Inventor
Maria Inmaculada Campins Bernadas
Nuria Jimenez Ridruejo
Roman Vidal Abad
Nuria Carreras Perdiguer
Maria Del Carmen Martinez San Jartin
Francisco Javier Galan Valdivia
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40857591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31880(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of UY31880A publication Critical patent/UY31880A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen compocisiones farmacéuticas que contienen un medicamento antibiótico de fluoroquinolona. Las composiciones presentan mayor homogeneidad, mejor biodisponibilidad, menor turbidez o una combinación de dichas características.Las composiciones se pueden utilizar como composiciones óticas o nasales; pero resultan particularmente útiles como composiciones oftálmicas.
UY0001031880A 2008-06-09 2009-06-08 Composiciones farmacéuticas mejoradas que contienen un medicamento antibiótico de fluoroquinolona UY31880A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5987708P 2008-06-09 2008-06-09

Publications (1)

Publication Number Publication Date
UY31880A true UY31880A (es) 2009-11-10

Family

ID=40857591

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031880A UY31880A (es) 2008-06-09 2009-06-08 Composiciones farmacéuticas mejoradas que contienen un medicamento antibiótico de fluoroquinolona

Country Status (16)

Country Link
US (2) US8450311B2 (es)
EP (1) EP2299974A1 (es)
JP (1) JP5509201B2 (es)
KR (1) KR101587056B1 (es)
CN (3) CN103550141A (es)
AR (1) AR072071A1 (es)
AU (1) AU2009257778B2 (es)
BR (1) BRPI0914971A2 (es)
CA (1) CA2726616A1 (es)
CL (1) CL2009001379A1 (es)
MX (1) MX2010012933A (es)
RU (1) RU2494727C2 (es)
TW (2) TWI495469B (es)
UY (1) UY31880A (es)
WO (1) WO2009151974A1 (es)
ZA (1) ZA201008543B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
TWI495469B (zh) 2008-06-09 2015-08-11 Alcon Res Ltd 含有氟喹諾酮抗生素藥物之經改良藥學組成物
CN103181892A (zh) * 2013-02-20 2013-07-03 南京恒道医药科技有限公司 盐酸莫西沙星滴眼液及其制备方法
CN105687127B (zh) * 2016-01-29 2018-09-28 上海利康瑞生物工程有限公司 关节腔用盐酸莫西沙星几丁糖注射液及其制备方法
CN110354074A (zh) * 2019-08-16 2019-10-22 合肥华威药业有限公司 一种缓释型盐酸莫西沙星眼用制剂及其制备方法
CN113797163B (zh) * 2020-06-17 2023-07-14 成都瑞沐生物医药科技有限公司 一种滴眼给药防治干性黄斑病变和视网膜光损伤的眼用制剂
US11298315B2 (en) 2020-08-26 2022-04-12 Somerset Therapeutics, Llc. Triamcinolone and moxifloxacin compositions
US11484538B2 (en) 2020-08-26 2022-11-01 Somerset Therapeutics, Llc Bromfenac, prednisolone, and moxifloxacin compositions and methods
US12016855B2 (en) 2020-08-26 2024-06-25 Somerset Therapeutics, Llc Prednisolone and moxifloxacin compositions and methods
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
JP3337218B2 (ja) * 1992-05-06 2002-10-21 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるホウ酸塩−ポリオール複合体の使用
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
KR100366676B1 (ko) 1996-12-13 2003-01-14 알콘 래보레이토리스, 인코퍼레이티드 안과용 조성물에 저분자량 아미노 알코올을 사용하는 방법
RU2130189C1 (ru) 1997-02-20 1999-05-10 Александр Сергеевич Парфенов Способ определения тканевого холестерина кожи
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
ATE245451T1 (de) 1998-04-07 2003-08-15 Alcon Lab Inc Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
AR020661A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6716830B2 (en) * 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6166012A (en) 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same
CN1384745A (zh) 1999-11-01 2002-12-11 爱尔康公司 含有一种氟喹诺酮抗生素和黄原酸胶的药物组合物
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid
DK1305033T3 (da) 2000-07-28 2005-01-31 Alcon Inc Farmaceutiske pæaparater indeholdende tobramycin og xanthangummi
WO2002049627A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
US20060141059A1 (en) 2004-12-27 2006-06-29 Alcon, Inc. Self-preserved ophthalmic pharmaceutical compositions containing tobramycin
CA2666058A1 (en) * 2006-10-12 2008-04-17 Kyorin-Pharmaceutical Co., Ltd. Aqueous liquid preparation comprising gatifloxacin
CA2666440A1 (en) * 2006-10-12 2008-04-17 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid preparation having improved intraocular gatifloxacin penetration
US7795316B1 (en) 2007-12-19 2010-09-14 Alcon Research, Ltd. Topical ophthalmic compositions containing tobramycin and dexamethasone
TWI495469B (zh) 2008-06-09 2015-08-11 Alcon Res Ltd 含有氟喹諾酮抗生素藥物之經改良藥學組成物
EP2309980A1 (en) 2008-07-08 2011-04-20 S.I.F.I. Societa' Industria Farmaceutica Italiana Ophthalmic compositions for treating pathologies of the posterior segment of the eye

Also Published As

Publication number Publication date
AU2009257778B2 (en) 2014-09-11
WO2009151974A1 (en) 2009-12-17
CL2009001379A1 (es) 2010-09-10
CN103550141A (zh) 2014-02-05
TW201503909A (zh) 2015-02-01
CA2726616A1 (en) 2009-12-17
TW201000102A (en) 2010-01-01
CN104814961A (zh) 2015-08-05
JP5509201B2 (ja) 2014-06-04
AR072071A1 (es) 2010-08-04
US8450311B2 (en) 2013-05-28
US20090306128A1 (en) 2009-12-10
ZA201008543B (en) 2012-02-29
BRPI0914971A2 (pt) 2017-06-20
AU2009257778A1 (en) 2009-12-17
JP2011522823A (ja) 2011-08-04
RU2494727C2 (ru) 2013-10-10
TWI544934B (zh) 2016-08-11
CN102056590A (zh) 2011-05-11
US9114168B2 (en) 2015-08-25
TWI495469B (zh) 2015-08-11
KR20110039219A (ko) 2011-04-15
US20130137715A1 (en) 2013-05-30
KR101587056B1 (ko) 2016-01-21
RU2010154545A (ru) 2012-07-20
MX2010012933A (es) 2011-01-25
EP2299974A1 (en) 2011-03-30

Similar Documents

Publication Publication Date Title
UY31880A (es) Composiciones farmacéuticas mejoradas que contienen un medicamento antibiótico de fluoroquinolona
CY1122687T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο
UY32259A (es) Nuevos compuestos de hidroxiareno, preparados farmaceuticos que los contienen y aplicaciones
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
MX2014012695A (es) Derivados de isoindolona.
CY1116424T1 (el) Παραγωγο αδενινης ως αναστολεας ρι3κ
CO6700831A2 (es) Derivados de pirazina como bloqueadores de enac
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
CL2008001301A1 (es) Compuestos derivados de heterociclos de nitrogeno; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una condicion inflamatoria o alergica, tal como una enfermedad inflamatoria u obstructiva de las vias respiratorias mediada por el bloqueo del canal de sodio epitelial.
BR112015022674A2 (pt) inibidores de bromodomínio
MA33939B1 (fr) 5-alcynyl-pyrimidines
UY30328A1 (es) Derivados de 2-piridona, procesos de preparacion, composiciones conteniéndolos y aplicaciones.
ECSP13012448A (es) Nuevas aminopirazoloquinazolinas.
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
CY1120435T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν κρυσταλλικες μορφες του μονοενυδρου υδροχλωρικου (r)-7-χλωρο-ν-(κινουκλιδινο-3-υλο) βενζο(β)θειοφαινο-2-καρβοξαμιδιου
UY33201A (es) Compuestos de pirazol como antagonistas de crth2.
IN2014CN03597A (es)
WO2013171764A3 (en) Ophthalmic formulations
UY32673A (es) Nuevas pirimidinas, composiciones farmaceuticas que las contienen, procedimientos de preparaciones y su aplicacion como medicamentos
CR20110210A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
DOP2012000170A (es) Proceso para la fabricacion de un agente farmaceuticamante activo
CR11057A (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
DOP2014000263A (es) Métodos de quelatos de oligonucleótidos
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
DOP2014000252A (es) (R)-Nifuratel, su Uso para el Tratamiento de Infecciones y Síntesis de (R) y (S)-Nifuratel